Table: begin end state 1 28 cytoplasmic 29 50 transmembrane 51 55 non-cytoplasmic 56 76 transmembrane 77 103 cytoplasmic 104 128 transmembrane 129 134 non-cytoplasmic 135 156 transmembrane 157 164 cytoplasmic 165 187 transmembrane 188 215 non-cytoplasmic 216 239 transmembrane 240 259 cytoplasmic 260 279 transmembrane 280 298 non-cytoplasmic 299 321 transmembrane 322 346 cytoplasmic 347 369 transmembrane 370 374 non-cytoplasmic 375 399 transmembrane 400 417 cytoplasmic 418 439 transmembrane 440 444 non-cytoplasmic 445 464 transmembrane 465 481 cytoplasmic
Input: >WP_050461858.1 NCBI__GCF_001189915.1:WP_050461858.1 MHDPTQQFQKIIERERGLQRSLTPGQMSMIAIGGAIGTGLFLGSGFAIGFAGPSVLLSYA IGAVIAIVLMGCLAEMTVAHPTSGSFGAYAEHYISPWAGFMVRYAYWACIVLAVGTEVTA IALYMKYWFPAVPGWFWIASFSAALVLINAFSVKVFGAVEYWFSLIKIAAIVGFILLGAY IVFVAPASLANVGGTAQLAGFHHYVEHGGFFPHGAWGMWVAVIIAIFSYLSIEMIAVAAG EAKDPETAVTSAFRSTVVRLVLFYLLTLALMLAIVPWTAASHDRSPFVMVMEAINTPGAA GVINFVVLVAALSSMNSQLYITTRMMFSLSRGGYAPQRLGQVNRRGVPLAALLLSTVGIA LAVLLSVVYPDASFTIMMAIAMFGALFTWMMIFVTHYFFRRHWNRHGKIPLRFRMIGFPV LTLLGAGLMLAIMTTTLFVAEFRMTLIFGVPFLILLSLAYFFWYGRRASAPVRDTASKLS S
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server